Nym Recognized in Healthcare Technology Report’s Top 100 Companies
Nym, a leader in autonomous medical coding, has been recognized in The Healthcare Technology Report’s list of Top 100 Healthcare Technology Companies for 2024. This accolade highlights Nym’s significant contribution…
Alloy Therapeutics Partners with Takeda to Develop Cell Therapy Platform
Alloy Therapeutics Inc., a biotechnology ecosystem company focused on democratizing access to advanced drug discovery technologies, has announced a strategic collaboration and licensing agreement with Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK).…
STIMIT Enrolls Patients in Trial for Noninvasive Diaphragm Neurostimulation Device
STIMIT AG announced today that it is enrolling patients in its FDA Investigational Device Exemption (IDE) clinical trial, the “STIMIT ACTIVATOR 1 PIVOTAL STUDY,” in collaboration with leading clinical centers…
Signature Healthcare Partners with NRC Health to Enhance Patient Experience and Workforce Engagement
Signature Healthcare has partnered with NRC Health to strengthen its network with human-centered healthcare solutions and advanced, data-driven insights that foster a deeper understanding of patients, employees, and communities. This…
Laekna Partners with Lilly to Develop LAE102, Monoclonal Antibody for Obesity
Laekna, Inc. (2105.HK), a global biotech company focused on developing novel therapies for metabolic and cancer diseases, is excited to announce a clinical collaboration with Eli Lilly and Company (Lilly),…
DT Research and swyMed Power Washington County Medical Center’s EMS Telemedicine Services
DT Research, a leading provider of purpose-built computing solutions for vertical markets, and swyMed™, a top provider of telemedicine and connectivity solutions, announced that Washington County Regional Medical Center (WCRMC)…
MediaLab Rebrands as Vastian, Expands into Hospital Quality and Accreditation
After nearly 30 years as a leader in lab quality management, MediaLab has announced its rebrand to Vastian. This change reflects the company’s growth and expansion to address the broader…
Puma Biotechnology Launches ALISCA™-Breast1 Phase II Trial of Alisertib in HR+/HER2- Metastatic Breast Cancer
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, has announced the launch of its ALISCA™-Breast1 Phase II trial (PUMA-ALI-1201; NCT06369285). The study will evaluate alisertib, in combination with endocrine therapy,…
Tanner Becomes First Community Cancer Care Provider to Offer Varian’s HyperSight
Tanner Cancer Care’s newly expanded Roy Richards, Sr. Cancer Center is not only visually impressive but also features the latest advancements in cancer treatment technology. Tanner Cancer Care’s newly expanded…
Pharmanovia In-Licenses Catumaxomab from Lindis Biotech for Malignant Ascites
Pharmanovia, a global pharmaceutical company focused on commercializing innovative medicines and revitalizing established ones, today announced the expansion of its oncology portfolio with a new licensing agreement for catumaxomab. This…
Study in Heart Rhythm Shows AI Algorithms Cut Alert Burden with PaceMate’s Data Capabilities
A recent study published in Heart Rhythm highlights how artificial intelligence (AI) algorithms embedded in Medtronic’s LINQ II implantable loop recorders (ILRs) significantly reduce alert and episode burdens. This is…
Peek Launches First-Ever ‘Prescription Marketplace’ to Revolutionize Employer Benefits
While every company wants to support their employees’ health, businesses of all sizes face challenges with rising healthcare costs and complex, confusing benefit plans. Prescription medications can be a tough…